Explore All Access
Check if your research matches the topics covered in ESMO Open?
- Degree of match
- Common matching concepts
- Additional journal recommendations
ESMO Open : Impact Factor & More
eISSN: 2059-7029pISSN: 2059-7029
Open AccessShare this on:
Check your submission readiness
Find out how your manuscript stacks up against 24 technical compliance and 6 language quality checks.
ESMO Open Key Metrics
CiteScore 
6.6
SNIP
1.43
Time to Accept
3
Mo
Time to Publish
View Chart Mo
Time to Publish
Sign up now and unlock a detailed chart of Time to publish for this journal
% of papers by time taken from submission to publication
0 to 3 months22%
4 to 6 months55%
7 to 9 months17%
Above 9 months6%
Did you find this useful?
Topics Covered on ESMO Open
Cancer
Assay
Lung cancer
Overall survival
Adjuvant
Homologous recombination
Immunotherapy
Progression-free survival
Breast cancer
Immune checkpoint
Melanoma
Toxicity
Body mass index
Endoplasmic reticulum
Epidermal growth factor receptor
Irradiation
Colorectal cancer
Confidence interval
Oxidative stress
Clinical trial
ESMO Open Journal Specifications
| Overview | |
| Publisher | ELSEVIER |
| Language | English |
| Frequency | Bi-monthly |
| Article Processing Charges | EUR 3000 |
| Publication Time | 10 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Language | English |
| Society/Institute/Sponsor | European Society for Medical Oncology |
| Frequency | Bi-monthly |
| Publication Start Year | 2016 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| License type | CC BY, CC BY-NC-ND |
| OA statement | Visit website |
View less
Planning to publish in ESMO Open ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in ESMO Open
Challenges in using tumor mutational burden as a post-treatment biomarker
- 1 Dec 2024
- ESMO Open
Identifying predictors of treatment response and molecular changes induced by neoadjuvant chemotherapy and endocrine therapy in hormone receptor-positive/HER2-negative breast cancer: the NEOENDO translational study
- 1 Dec 2024
- ESMO Open
Corrigendum to “mFOLFOX6 versus mFOLFOX6 + aflibercept as neoadjuvant treatment in MRI-defined T3-rectal cancer: a randomized phase-II-trial of the German Rectal Cancer Study Group (CAO/ARO/AIO 0214) and the ABCSG (R-06)”
- 1 Dec 2024
- ESMO Open
Collagen signature adds prognostically significant information to staging for breast cancer
- 1 Dec 2024
- ESMO Open
Lurbinectedin in extensive-stage small-cell lung cancer: a brief report of the IFCT-2105 LURBICLIN study
- 1 Dec 2024
- ESMO Open
Surface-based deep inspiration breath-hold radiotherapy in left-sided breast cancer: final results from the SAVE-HEART study
- 1 Dec 2024
- ESMO Open
Challenges in using tumor mutational burden as a post-treatment biomarker
- 1 Dec 2024
- ESMO Open
Identifying predictors of treatment response and molecular changes induced by neoadjuvant chemotherapy and endocrine therapy in hormone receptor-positive/HER2-negative breast cancer: the NEOENDO translational study
- 1 Dec 2024
- ESMO Open
Corrigendum to “mFOLFOX6 versus mFOLFOX6 + aflibercept as neoadjuvant treatment in MRI-defined T3-rectal cancer: a randomized phase-II-trial of the German Rectal Cancer Study Group (CAO/ARO/AIO 0214) and the ABCSG (R-06)”
- 1 Dec 2024
- ESMO Open
Collagen signature adds prognostically significant information to staging for breast cancer
- 1 Dec 2024
- ESMO Open
Lurbinectedin in extensive-stage small-cell lung cancer: a brief report of the IFCT-2105 LURBICLIN study
- 1 Dec 2024
- ESMO Open
Surface-based deep inspiration breath-hold radiotherapy in left-sided breast cancer: final results from the SAVE-HEART study
- 1 Dec 2024
- ESMO Open
Compare Similar Journals with ESMO Open
Select Journals to Compare with ESMO Open
Total journals - 9
You can select up to 3 Journals at a time
Annals of Oncology
Publisher: ELSEVIER
Journal of Clinical Oncology
Publisher: LIPPINCOTT WILLIAMS & WILKINS
Cancers
Publisher: MDPI
Cancer Research
Publisher: AMER ASSOC CANCER RESEARCH
Frontiers in Oncology
Publisher: FRONTIERS MEDIA SA
BMC Cancer
Publisher: BMC
European Journal of Cancer
Publisher: ELSEVIER SCI LTD
Clinical Cancer Research
Publisher: AMER ASSOC CANCER RESEARCH
Cancer Medicine
Publisher: WILEY
0 Journals Selected to compare with
ESMO Open
Compare journals across 7 parameters SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
Get detailed Journal comparison report on your email by signing up
FAQs on ESMO Open
How long has ESMO Open been actively publishing? 
ESMO Open has been in operation since 2016 till date.
What is the publishing frequency of ESMO Open?
ESMO Open published with a Bi-monthly frequency.
How many articles did ESMO Open publish last year?
In 2023, ESMO Open publsihed 1079 articles.
What is the eISSN & pISSN for ESMO Open?
For ESMO Open, eISSN is 2059-7029 and pISSN is 2059-7029.
What is Citescore for ESMO Open?
Citescore for ESMO Open is 6.6.
What is SNIP score for ESMO Open?
SNIP score for ESMO Open is 1.43.
Who is the publisher of ESMO Open?
ELSEVIER is the publisher of ESMO Open.
